- Acid-Suppressives and Antibiotics in Infancy
Acid-Suppressives and Antibiotics in Infancy
Bottom Line: The use of acid-suppressing medications or antibiotics in the first 6 months of infancy was associated with an increased risk for the subsequent development of allergic diseases in childhood.
Why The Research Is Interesting: Allergic diseases and asthma have been on the rise over several decades. Medications that can alter the human microbiome may contribute to the rise of allergic diseases. Acid-suppressing medicines and antibiotics can contribute to a microbial imbalance in the gut (intestinal dysbiosis).
Who and When: 792,130 children born between October 2001 and September 2013 and enrolled in the military health system until at least age 1
What (Study Measures): Any dispensed prescription for a histamine-2 receptor antagonist (H2RA), proton pump inhibitor (PPI) or antibiotic (exposures) in the first six months of life; allergic disease defined as the presence of food allergy, anaphylaxis, asthma, atopic dermatitis (eczema), allergic rhinitis (hay fever). allergic conjunctivitis (eye inflammation), urticaria (rash), contact dermatitis (skin rash), medication allergy or other allergy (outcomes)
How (Study Design): This was an observational study. Researchers were not intervening for purposes of the study and they cannot control natural differences that could explain the study findings.
Authors: Edward Mitre, M.D., of the Uniformed Services University of the Health Sciences, Bethesda, Maryland, and coauthors
The use of acid-suppressing medicines was associated with increased risks for all major categories of allergic disease, especially food allergy. Antibiotics also were associated with increased risk of all major categories for allergic disease.
Study Limitations: It is possible that acid-suppressing medicines or antibiotics were given for allergic diseases that were misdiagnosed, although the authors doubt this can explain all their findings. The mechanisms by which acid-suppressing medicines and antibiotics might increase allergic sensitization also are not fully understood but potential ones could include intestinal dysbiosis and, for acid-suppressing medicines, decreased protein digestion in the stomach.
To our knowledge, this is the largest study demonstrating an association between H2RAs, PPIs and antibiotics given in infancy and the subsequent development of allergic diseases. The results are consistent with those of prior studies and have biologic plausibility. Thus, this study provides further impetus that antibiotics and acid-suppressive medications should be used in infancy only in situations of clear clinical benefit. Additional studies will be required to confirm causality and determine the mechanism of action.
DISCLAIMER: Bankix Systems Ltd is the registered name of a Canadian firm since 2003, and bankixsystems.com is its OFFICIAL website. Besides these entities, we have no relationship with anyone, business, website, or any other entity anywhere in the world, claiming to be Bankix Systems, or using a similar name, and creating the impression that it has some connection with our company. We do not endorse and are therefore, not responsible for any act or lack thereof by any such entity. Bankix Systems Ltd is also not responsible for the content of the description of products and services linked to our site nor does it necessarily endorse them. The information here provided is not for diagnosing/treating your health concerns. Kindly contact your doctor or health care professional for all your healthcare requirements.
Contents © 2003-2019, BankixSystems.com. All rights reserved. Unauthorized reproduction strictly prohibited. Information based on best available resources. Opinions are current and subject to change.